Status:
UNKNOWN
Modified SALT Score for Alopecia Areata
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Alopecia Areata
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.
Eligibility Criteria
Inclusion
- localized scalp AA ( 2 patches and ≤50% scalp involvement , duration more than 6 months) • patients who did not receive any medication for at least 2 months before starting the study and those who agreed to join the study and signed written consent.
Exclusion
- • pregnant, and lactating females
- Alopecia totalis or universalis or ophiasis or cicatritial alopecia
- Usage of systemic treatment of alopecia areata 2 months prior to the study.
- Any scalp lesion within the treated area
- Bleeding diathesis, severe anemia or platelet disorders
- Medical conditions such as autoimmune diseases.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04412148
Start Date
January 1 2020
End Date
August 1 2020
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr El Ainy university hospital, Faulty of medicine,Cairo university
Cairo, Egypt